Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...

The U.S. Department of Health and Human Services (HHS) terminated senior advisor Dr. Steven Hatfill after six months in his ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for ...

The study, published in the journal Nature, showed the jabs provided an immunity boost that helped extend survival for certain skin and lung cancers.

A top biosecurity adviser at the Department of Health and Human Services who believed messenger RNA Covid vaccines should be ...

Researchers found that COVID-19 mRNA vaccines significantly increased survival in lung and skin cancer patients undergoing immunotherapy. The vaccine appears to prime the immune system in a powerful, ...

Steven Hatfill, a senior biosecurity adviser at the Department of Health and Human Services (HHS), was dismissed after ...

A 46% premium paid for RNA candidates reflects what the pharma giant has sought to do for the last few years: aim at ...

The mRNA vaccines developed to fight COVID-19 during the pandemic "did have a very important impact in decreasing hospitalizations, severe pneumonia and death." ...